| Bioactivity | FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection[1][2]. |
| Invitro | FSL-1 significantly reduces HSV-2 replication in vitro. FSL-1 reduces HSV-2 replication in human vaginal epithelial cells (EC)[1].FSL-1 induces significant resistance to experimental genital HSV-2 infection through elaboration of a specific cytokine response profile[1].FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway[1][2]. Cell Viability Assay[1] Cell Line: |
| Name | FSL-1 |
| CAS | 322455-70-9 |
| Shortening | S-(2, 3-Bispalmitoyloxypropyl)-CGDPKHPKSF |
| Formula | C84H140N14O18S |
| Molar Mass | 1666.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
FSL-1
CAS: 322455-70-9 F: C84H140N14O18S W: 1666.16
FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.